Clinical trial
Validation of Bulbicam for Use on Patient Suffering From Parkinson and Ataxia
NCT05680571 is registered in ClinicalTrials.gov with Meddoc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of Bulbicam for Use on Patient Suffering From Parkinson and Ataxia
- Lead sponsor
- Meddoc
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 19, 2022
- Completion date
- March 30, 2023
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.